Evidence map›Paper›PMID 28300834›Full record

ArticleCell death & disease2017

Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations.

Joel Fulton, Bismoy Mazumder, Jonathan B Whitchurch, Cintia J Monteiro, Hilary M Collins, Chun M Chan, Maria P Clemente, Miguel Hernandez-Quiles, Elizabeth A Stewart, Winfried M Amoaku and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Mouse NR2E3FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Joel FultonSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Bismoy MazumderSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Jonathan B WhitchurchSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Cintia J MonteiroSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Hilary M CollinsSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Chun M ChanSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Maria P ClementeSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Miguel Hernandez-QuilesSchool of Pharmacy, University of Nottingham, Nottingham, UK.
Elizabeth A StewartDivision of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Winfried M AmoakuDivision of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Paula M MoranSchool of Psychology, University of Nottingham, Nottingham, UK.
Nigel P MonganSchool of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Jenny L PerssonDivision of Experimental Cancer Research, Department of Translational Medicine, Lund University, Clinical Research Centre, Malmö, Sweden.
Simak AliDepartment of Surgery and Cancer, Imperial College London, London, UK.
David M HeerySchool of Pharmacy, University of Nottingham, Nottingham, UK.
University of Nottingham · GBCornell University · USImperial College London · GBUmeå University · SE

Funding

Biotechnology and Biological Sciences Research Council BB/J014508/1Cancer Research UK 11643Cancer Research UK C1506/A11643
6 · The paper itself

Abstract

Photoreceptor-specific nuclear receptor (PNR/NR2E3) and Tailless homolog (TLX/NR2E1) are human orthologs of the NR2E group, a subgroup of phylogenetically related members of the nuclear receptor (NR) superfamily of transcription factors. We assessed the ability of these NRs to form heterodimers with other members of the human NRs representing all major subgroups. The TLX ligand-binding domain (LBD) did not appear to form homodimers or interact directly with any other NR tested. The PNR LBD was able to form homodimers, but also exhibited robust interactions with the LBDs of peroxisome proliferator-activated receptor-γ (PPARγ)/NR1C3 and thyroid hormone receptor b (TRb) TRβ/NR1A2. The binding of PNR to PPARγ was specific for this paralog, as no interaction was observed with the LBDs of PPARα/NR1C1 or PPARδ/NR1C2. In support of these findings, PPARγ and PNR were found to be co-expressed in human retinal tissue extracts and could be co-immunoprecipitated as a native complex. Selected sequence variants in the PNR LBD associated with human retinopathies, or a mutation in the dimerization region of PPARγ LBD associated with familial partial lipodystrophy type 3, were found to disrupt PNR/PPARγ complex formation. Wild-type PNR, but not a PNR309G mutant, was able to repress PPARγ-mediated transcription in reporter assays. In summary, our results reveal novel heterodimer interactions in the NR superfamily, suggesting previously unknown functional interactions of PNR with PPARγ and TRβ that have potential importance in retinal development and disease.

Indexed as

Cell LineCell Line, TumorDimerizationHEK293 CellsHumansMutationNuclear Receptor Subfamily 1, Group D, Member 1Orphan Nuclear ReceptorsPPAR gammaProtein ConformationRetinaRetinal DiseasesThyroid Hormone Receptors betaTranscription FactorsNR2E3 protein, humanNuclear Receptor Subfamily 1, Group D, Member 1Orphan Nuclear ReceptorsPPAR gammaThyroid Hormone Receptors betaTranscription Factors

Identifiers

PMID28300834
PMCPMC5386588
OpenAlexW2595068089

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.